Search

everythinglearnresearchcommunity

for

Search:↓

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Testosterone's muscle-building effects do not require its conversion to DHT.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride may affect PNMT, causing side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.

Finasteride reduces hair growth and is safe for women with excessive hair.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Finasteride negatively affects fish reproduction and gonadal development.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Finasteride exposure harms tadpole reproduction and hormone balance.